Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

ACS medicinal chemistry letters·2026
Same author

CRUSH-Cleavage Rules Using SMIRKS Heuristics: an enhanced molecular fragmentation algorithm.

Journal of cheminformatics·2026
Same author

Structural diversity and chemical space analysis of a PROTAC database using unsupervised machine learning.

Scientific reports·2026
Same author

Chemical Space Exploration of a Database of Covalent Binders in the PDB.

Journal of chemical information and modeling·2026
Same author

The (r)evolution of chemical space and molecular modeling: a time-resolved perspective.

Journal of computer-aided molecular design·2026
Same author

On the pursuit of the true impact of our actions in science.

Frontiers in research metrics and analytics·2026

関連する実験動画

Updated: Jul 6, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

PROTACの薬剤発見のためのコンピューティング方法の進歩

Massyel S Martinez-Cortés1, Carlos A Velázquez-Martínez2, José L Medina-Franco1

  • 1DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.

Drug discovery today
|February 19, 2026
PubMed
まとめ

タンパク質分解を標的とするキメラ (PROTACs) は,標的タンパク質を分解することによって,新しい薬剤発見アプローチを提供します. このレビューでは,PROTACの設計,最適化,および臨床翻訳を支援するコンピューティングツールを詳細に説明します.

キーワード:
人工知能 (AI) は,人工知能 (AI) を利用する.化学情報学 化学情報学コンピュータによる分子設計.機械学習 (Machine Learning) とは,機械学習 (Machine Learning) とは,機械学習 (Machine Learning) と呼ばれるものです.分子ダイナミクス 分子ダイナミクス

さらに関連する動画

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

関連する実験動画

Last Updated: Jul 6, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

科学分野:

  • ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
  • 薬用化学 薬用化学について
  • コンピューティング・ケミストリー

背景:

  • タンパク質分解を標的とするキメラ (PROTACs) は,標的型タンパク質分解を提供することで,薬剤発見における重要な進歩を表しています.
  • PROTACは,複雑な構造と非伝統的な薬物のような特性により,ユニークな設計と最適化課題を提示しています.

研究 の 目的:

  • PROTACの開発をサポートするコンピューティングの進歩の包括的な概要を提供します.
  • 弾頭とリンク器の選択,三元複合モデリング,劣化効率の予測,ADMETプロフィールなど,PROTAC設計の重要な側面のためのツールを強調する.
  • PROTACの設計を改善し,臨床翻訳を加速するための現在の限界と将来の方向性を議論する.

主な方法:

  • PROTAC開発におけるコンピューティングツールに関する最近の文献のレビュー.
  • 化学情報学,構造バイオ情報学,分子モデリング,機械学習を含むコンピューティングアプローチの分類.
  • 特定のPROTAC設計要素とプロパティの予測のためのツールの分析.

主要な成果:

  • PROTACの研究に適用できる多様なコンピューティングリソースの特定.
  • 核弾頭/リンクヤー設計と三元複合モデリングに役立つコンピューティングツールの実証.
  • 劣化効率とADMET特性の予測能力を強調する.

結論:

  • 計算戦略は,PROTACの設計上の課題を克服するために不可欠です.
  • 化学情報学,バイオ情報学,機械学習の進歩は,PROTACの開発を加速しています.
  • 強化されたコンピューティングアプローチは,PROTACの設計効率と臨床翻訳を改善するための鍵です.